Agenda of the 155th meeting of the COST Senior Officials Committee, 14 July

Brussels, 02 Jul 2003

Full text of Document X03176/03
Suite of documents X03176/03

1. Adoption of the agenda

2. Approval of Summary of Conclusions of the 154th meeting (COST 256/03)

3. Information from:
- the Chair
- the Italian EU Presidency
- the Secretariat
- delegations and the Commission services

4. Transition period and progress report on COST Office
- Contract negotiations between the ESF and the Commission

5. Requests for prolongation or extension of the duration of COST Actions

• COST A15: Reforming Social Protection Systems in Europe (6 months)
• COST A17: Small and Medium Enterprises, Economic Development and Regional Convergence in Europe (12 months)
• COST B12: Radiotracers for in vivo assessment of biological function (12 months)
• COST B14: Hyperbaric Oxygen Therapy (6 months)
• COST B15: Modelling during Drug Development (9 months)
• COST B17: Insulin resistance, obesity and diabetes mellitus in the elderly (12 months)
• COST B19: Molecular cytogenetics of solid tumours (12 months)
• COST D14: Functional Molecular Materials (18 months)
• COST 830: Microbial Inoculants in Agriculture and in the Environment (12 months)
• COST 845: Brucellosis in Animals and Man (12 months)
• COST 840: Bioencapsulation innovations and technologies (12 months)
• COST E15: Advances in the drying of wood (12 months)
• COST E20: Wood fibre cell wall structure (6 months)
• COST E22: Environmental optimisation of wood protection (4,5 months)

The decisions/recommendations of the Bureau will be communicated to the CSO separately prior to the meeting.

6. Mandate of JAF Chair/Second Vice-Chair of the CSO
- Expiration of present mandate in October 2003

7. Information on the Joint COST - ESF meeting

8. Any other business

Council Register